Search clinical trials for: NS Solution

Total 19418 results

Northwell Health
Next Science TM

Recruiting

Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone

Joint Infection

United States
University Medical Center of Southern Nevada

Completed

Does Intravenous Lactated Ringer Solution Raise Measured Serum Lactate?

Hyperlactatemia

United States
Next Science TM
TKL Research, Inc.

Completed

4-Day Primary Irritation Patch Test of MIS Solution

Healthy | Irritation/Irritant | Reactions Adverse
Second Affiliated Hospital, School of Medicine,...
Jinhua People's Hospital; Jinhua Municipal Central Hospital; Yiwu Central Hospital and other collaborators

Recruiting

The Relationship Between Normal Saline Infusion and Acute Kidney Injury in Heat Stroke

Heat Stroke

China
MemorialCare

Completed

A Study on the Effects of Dextrose Solutions on the Course of Labor

Labor
Ewha Womans University

Completed

Effects of Deer Bone Extract NS on Improvement in Cognitive-Bio-Markers of Cognitive Functions

Healthy Adults With Subjective Memory Complaints

Korea, Republic of
Children's Hospital of Philadelphia
American Academy of Pediatrics; Academic Pediatric Association

Completed

IV Glucose for Dehydration Treatment

Dehydration

United States
NS Pharma, Inc.
Nippon Shinyaku Co., Ltd.

Not yet recruiting

NS-050/NCNP-03 in Boys With DMD (Meteor50)

Duchenne Muscular Dystrophy

United States
NS Pharma, Inc.
Nippon Shinyaku Co., Ltd.

Recruiting

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United States
Nemours Children's Clinic
University of Florida

Completed

A Within Subjects Comparison of Two Antegrade Flushing Regimens in Children

Neurogenic Bowel | Fecal Incontinence

United States
University of Florence
Italian Cystic Fibrosis Research Foundation; Ospedale Meyer

Terminated

Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People

Cystic Fibrosis | Phlebitis

Italy
Wake Forest University Health Sciences
Community Blood Center of the Carolinas

Completed

Proving Hemodilution in a Human Model for Class I Hemorrhage

Wounds and Injuries | Shock | Hemorrhage | Hemodilution
Lustre Pharmaceutical Lab Co., Ltd

Unknown

An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD

Chronic Obstructive Pulmonary Disease
Glenmark Specialty S.A.

Completed

Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR) (GSP 301-304)

Seasonal Allergic Rhinitis (SAR)

United States
NS Pharma, Inc.

Completed

Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF

Primary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia Myelofibrosis

United States
University of Calgary

Withdrawn

Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion

Hemolytic-Uremic Syndrome

Canada
Université de Sherbrooke

Not yet recruiting

Efficacy of 20% Autologous Serum Drops in the Treatment of Corneal Epitheliopathy Associated With Antihypertensive Glaucoma Drops.

Glaucoma | Dry Eye | Corneal Disease | Corneal Epitheliopathy
Boehringer Ingelheim

Completed

A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE)

Parkinson Disease

United States, Canada
Butler Hospital
University of North Carolina, Chapel Hill; Neurolief Ltd.

Enrolling by invitation

EEG Biomarker Study for Participants in the Neurolief "MOOD" Trial

Depression

United States
Boehringer Ingelheim

Completed

An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type

Alzheimer Disease

United States, Canada
NS Pharma, Inc.
Nippon Shinyaku Co., Ltd.

Recruiting

Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

Churg-Strauss Syndrome | Eosinophilic Granulomatosis With Polyangiitis

United States, Japan
Hoffmann-La Roche

Completed

A Single Ascending Dose Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Volunteers.

Atherosclerosis

United States
Yijian Zhu

Recruiting

Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo

Vitiligo

China
NS Pharma, Inc.
Cooperative International Neuromuscular Research Group; Nippon Shinyaku Co.... and other collaborators

Completed

Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United States, Canada
National Center of Neurology and Psychiatry, Japan
Nippon Shinyaku Co., Ltd.

Completed

Exploratory Study of NS-089/NCNP-02 in DMD

Duchenne Muscular Dystrophy

Japan
Lee's Pharmaceutical Limited
CVie Therapeutics Co. Ltd.

Unknown

Istaroxime Infusion for 24 Hours in Chinese Healthy Volunteers

Healthy

China
Ahmed Mohamed ELbadawy

Unknown

Prophylaxis Versus Treatment for TURP Syndrome.

Transurethral Resection of Prostate Syndrome

Egypt
NeuShen Therapeutics

Not yet recruiting

First-into-human Study of NS-136 in Healthy Subjects

Healthy Subjects

Australia
Nippon Shinyaku Co., Ltd.

Active, not recruiting

Extension Study of NS-089/NCNP-02 in DMD

Duchenne Muscular Dystrophy (DMD)

Japan
National Center of Neurology and Psychiatry, Japan
Nippon Shinyaku Co., Ltd.

Completed

Exploratory Study of NS-065/NCNP-01 in DMD

Duchenne Muscular Dystrophy

Japan
NS Pharma, Inc.
Nippon Shinyaku Co., Ltd.

Completed

Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD (Galactic53)

Duchenne Muscular Dystrophy

Spain, United States, Russian Federation, Italy, China, Turkey
NS Pharma, Inc.
Nippon Shinyaku Co., Ltd.

Recruiting

Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

United States, Korea, Republic of, Malaysia, Italy, Germany, Poland, United Kingdom, Thailand, Turkey
Southeast University, China
National Health and Family Planning Commission, P.R.China

Completed

The Efficacy of Xuebijing Injection on Sepsis

Sepsis

China
Children's Hospital of Philadelphia
University of Pennsylvania; University of California, Davis; University of Utah

Completed

Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis: A Pilot Feasibility Study (PRoMPT BOLUS)

Shock, Septic

United States
Glenmark Specialty S.A.

Completed

Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR) (GSP 301-303)

Perennial Allergic Rhinitis

United States
NuSirt Biopharma

Completed

The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity

Obesity

United States
Postgraduate Institute of Medical Education and...

Recruiting

TXA Nebulization for the Treatment of Hemoptysis (TXA-NEB)

Hemoptysis

India
NS Pharma, Inc.
Nippon Shinyaku Co., Ltd.

Active, not recruiting

Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)

Duchenne Muscular Dystrophy

Korea, Republic of, Chile, Japan, China, United Kingdom, Netherlands, Spain, Norway, Russian Federation, Australia, Greece, Italy, New Zealand, Turkey, Mexico, Czechia, Canada
NS Pharma, Inc.
Cooperative International Neuromuscular Research Group; Nippon Shinyaku Co.... and other collaborators

Completed

Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United States, Canada
NS Pharma, Inc.

Approved for marketing

The Expanded Access Use of Viltolarsen in Duchenne Muscular Dystrophy With Confirmed Exon 53 Amenable Mutation

Muscular Dystrophy, Duchenne | DMD
Brian Miller
Brain & Behavior Research Foundation

Recruiting

Tocilizumab in Schizophrenia

Psychotic Disorders | Schizophrenia

United States
Maimonides Medical Center

Withdrawn

GnRH Agonist at Embryo Transfer: IVF Outcomes (GRAET)

Infertility | Infertility, Female | Infertility, Male

United States
VA Office of Research and Development

Terminated

VA CoronavirUs Research and Efficacy Studies-1 (VACURES-1)

COVID-19

United States, Puerto Rico
NS Pharma, Inc.
Nippon Shinyaku Co., Ltd.

Completed

Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53)

Duchenne Muscular Dystrophy

Korea, Republic of, Chile, Taiwan, China, United States, United Kingdom, Netherlands, Spain, Australia, Norway, Russian Federation, Greece, Italy, Turkey, Mexico, Canada, Hong Kong, New Zealand, Ukraine
Rutgers, The State University of New Jersey

Completed

Povidone-Iodine for Nasal Decolonization

Surgical Wound Infection | Preoperative Care | Methicillin-Resistant Staphylococcus Aureus

United States
University of California, San Diego

Completed

Hypertonic Saline as Therapy for Pediatric Concussion

Pain

United States
Glenmark Pharmaceuticals Ltd. India

Completed

To Study GSP 301 in Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Cionic, Inc.

Recruiting

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

Multiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting

United States
Glenmark Specialty S.A.

Completed

Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR) (GSP 301-305)

Seasonal Allergic Rhinitis (SAR)

United States
Black Tie Medical, Inc.

Active, not recruiting

Ovarian Rejuvenation Using Platelet Rich Plasma (PRP) & Autologous Tissue Stromal Vascular Fraction (tSVF) and Cell Enriched tSVF (OVAR-REJUV)

Hormone Disturbance | Perimenopausal Disorder | Ovarian Failure

United States

Search clinical trials for: NS Solution

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations